BIORETEC OY Asset Resilience Ratio
BIORETEC OY asset resilience ratio. BIORETEC OY (0TN) has an Asset Resilience Ratio of 26.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of BIORETEC OY to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of BIORETEC OY (2021–2025)
Asset resilience ratio of BIORETEC OY from 2021 to 2025. This chart shows how BIORETEC OY's Asset Resilience Ratio has changed over time. Read 0TN current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down BIORETEC OY's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 0TN current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.04 Million | 26.06% |
| Total Liquid Assets | €3.04 Million | 26.06% |
Asset Resilience Insights
- Very High Liquidity: BIORETEC OY maintains exceptional liquid asset reserves at 26.06% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BIORETEC OY Industry Peers by Asset Resilience Ratio
Compare BIORETEC OY's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
BIORETEC OY Asset Resilience Ratio by Year (2021–2025)
BIORETEC OY asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for BIORETEC OY.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 26.06% | €3.04 Million ≈ $3.56 Million |
€11.68 Million ≈ $13.65 Million |
+4.68pp |
| 2024-12-31 | 21.37% | €2.45 Million ≈ $2.87 Million |
€11.47 Million ≈ $13.42 Million |
-7.96pp |
| 2023-12-31 | 29.33% | €3.13 Million ≈ $3.65 Million |
€10.66 Million ≈ $12.46 Million |
+0.22pp |
| 2022-12-31 | 29.11% | €1.02 Million ≈ $1.19 Million |
€3.49 Million ≈ $4.08 Million |
-46.15pp |
| 2021-12-31 | 75.27% | €6.46 Million ≈ $7.55 Million |
€8.58 Million ≈ $10.03 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more